How does a VC source a unicorn startup at the early stage?

<p><a href="https://www.linkedin.com/in/ashishk/" target="_blank"><strong>Ashish Kumar</strong></a></p> <ul> <li>Partner, The Fundamentum Partnership (growth-focused VC Fund)</li> </ul> <p>Sharing his insights on:</p> <p>1. As a part of a VC firm, what got you interested in the healthcare sector?<br> 2. You had assessed several players in the pharma space, what were the 3 key factors that stood out for PharmEasy?<br> 3. Besides the team, what other factors drove you to commit to PharmEasy?<br> 4. In general, what makes a team shine over others when it comes to investment?<br> 5. Coming back to PharmEasy, you tweeted about channel relationships, margins, and supply chain as key differentiators, can you elaborate on that?<br> 6. So quite a cliche question, did you ever envisage that PharmEasy would turn up as a unicorn someday?<br> 7. From the founders' perspective, what should they focus on at the early stage, to become a leader in any sector?<br> 8. Finally, tell us about "Fundamentum Partnership," and what's your investment thesis?</p>